Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142.

Yang LX, Wei CL, Guo ML, Zhang Y, Bai F, Ma SG

Open source

DOI
10.18632/oncotarget.20935
Published
2017 Oct 17
Container
Oncotarget
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.20935,
  title = {Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142.},
  author = {Yang LX and Wei CL and Guo ML and Zhang Y and Bai F and Ma SG},
  year = {2017},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.20935},
  url = {https://doi.org/10.18632/oncotarget.20935}
}

RIS

TY  - JOUR
TI  - Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142.
AU  - Yang LX
AU  - Wei CL
AU  - Guo ML
AU  - Zhang Y
AU  - Bai F
AU  - Ma SG
PY  - 2017
JO  - Oncotarget
DO  - 10.18632/oncotarget.20935
UR  - https://doi.org/10.18632/oncotarget.20935
ER  - 

APA

LX, Y., CL, W., ML, G., Y, Z., F, B., & SG, M. (2017). Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142.. Oncotarget. https://doi.org/10.18632/oncotarget.20935

Source records